Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial

被引：0
作者：
Ghorayeb, Ghassan [1 ]
机构：
[1] West Virginia Univ, Eye Inst, Morgantown, WV USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2707
引用
收藏
页数：2
相关论文
共 50 条
[31]   Systematic Review of Safety Across the Phase 2 and 3 Clinical Trials of Intravitreal Aflibercept Injection in Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Diabetic Macular Edema [J].
Kitchens, John William .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[32]   Loading phase outcomes of intravitreal aflibercept 8 mg for treatment-naïve neovascular age-related macular degeneration [J].
Matsumoto, Hidetaka ;
Hoshino, Junki ;
Numaga, Saki ;
Asatori, Yosuke ;
Akiyama, Hideo .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025,
[33]   Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment Outcomes from the Phase 3 Program [J].
Do, Diana V. ;
Quan Dong Nguyen ;
Vitti, Robert ;
Berliner, Alyson J. ;
Gibson, Andrea ;
Saroj, Namrata ;
Soo, Yuhwen ;
Boyer, David S. .
OPHTHALMOLOGY, 2016, 123 (04) :850-857
[34]   One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema [J].
Bonyadi, Mohammad Hossein Jabbarpoor ;
Baghi, Ahmadreza ;
Ramezani, Alireza ;
Yaseri, Mehdi ;
Soheilian, Masoud .
OPHTHALMOLOGY RETINA, 2018, 2 (05) :428-440
[35]   Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with "Treat-and-Extend" Regimen-Its Usefulness and Problems [J].
Chujo, Shinichiro ;
Sugimoto, Masahiko ;
Sasaki, Taku ;
Matsui, Yoshitsugu ;
Kato, Kumiko ;
Ichio, Atsushi ;
Miyata, Ryohei ;
Matsubara, Hisashi ;
Kondo, Mineo .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) :1-12
[36]   Impact of baseline central retinal thickness (CRT) on vision among patients with diabetic macular edema (DME): post hoc analysis of the phase 2/3 PHOTON trial [J].
Sambhara, Deepak .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[37]   Intravitreal aflibercept 8 mg in patients with polypoidal choroidal vasculopathy (PCV): A Phase 3 PULSAR trial subgroup analysis [J].
Wong, Tien Y. ;
Heier, Jeffrey S. ;
Zhang, Xin ;
Machewitz, Tobias ;
Schulze, Andrea ;
Leal, Sergio .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
[38]   Effect of Baseline Central Retinal Thickness (CRT) and Best Corrected Visual Acuity (BCVA) on Treatment Outcomes With Intravitreal Aflibercept Injection (IAI) or Macular Laser Photocoagulation in Diabetic Macular Edema (DME) [J].
Ogura, Yuichiro ;
Feltgen, Nicolas ;
Korobelnik, Jean-Francois ;
Midena, Edoardo ;
Katz, Todd A. ;
Teukmantel, Claudia ;
Metzig, Carola ;
Zeitz, Oliver .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[39]   Anatomic Outcomes with Dexamethasone Intravitreal Implant in Diabetic Macular Edema: a Pooled Analysis of Two Randomized Phase 3 Trials [J].
Danis, Ronald P. ;
Sadda, Srinivas R. ;
Cui, Harry ;
Li, Xiao-Yan ;
Hashad, Yehia ;
Whitcup, Scott M. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[40]   Efficacy of Aflibercept (8 mg) for Diabetic Macular Edema in Vitrectomized Eyes Refractory to the Other Anti-VEGF Drug Therapies: A Report of Three Cases [J].
Kashiwagi, Ikumi ;
Nonaka, Ryota ;
Sasaki, Shotaro ;
Yamamoto, Takuto ;
Yasuda, Kanako ;
Shimura, Masahiko .
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2025, 18 :465-471
12345